Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Grifols SA (GRF) Ord Eur0.25 A Shares

Sell:€24.24 Buy:€24.25 Change: €0.04 (0.16%)
IBEX 35:0.00%
Prices delayed by at least 15 minutes | Switch to live prices |
Change: €0.04 (0.16%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: €0.04 (0.16%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Grifols SA is a Spain-based company engaged in the biopharmaceuticals manufacture. The Company’s activities are divided into four business segments: Bioscience, Hospital, Diagnostic and Raw materials. The Bioscience division focuses on the research, development, manufacturing and marketing of products derived from human plasma for therapeutic use. The Hospital division offers non-biological pharmaceutical products and medical supplies for hospital pharmacy. The Diagnostic division provides clinical analysis and laboratory testing tools to laboratories, hospitals and blood banks. The Raw materials division includes sales of intermediate biological products, as well as manufacturing services to third parties. The Company operates production facilities in Spain, the United States, Mexico and Australia, among others. It controls numerous subsidiaries, such as Kiro Grifols SL.

Contact details

C/ Jesus y Maria, 6
+34 (935) 710000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
€14.09 billion
Shares in issue:
684.14 million
Madrid Stock Exchange

Key personnel

  • Victor Grifols Deu
    Co-Chief Executive Officer, Executive Director
  • Raimon Grifols Roura
    Co-Chief Executive Officer, Executive Director
  • Alfredo Arroyo Guerra
    Chief Financial Officer
  • Joel Abelson
    President, Bioscience Commercial Division
  • Albert Coma-Cros
    President, Grifols Worldwide Operations
  • Gregory Gene Rich
    President and Chief Executive Officer - GSSNA
  • Albert Grifols Roura
    President - Bio Supplies Division
  • Eduardo Raimundo Herrero Jimenez
    President, Grifols Bioscience Industrial Group
    President - Hospital Commercial Division
  • Jose Oriol Dunach
    President - Diagnostic Industrial Group

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.